| CDKAL1 | |
|---|---|
| Protein Name | CDK5 Regulatory Subunit Associated Protein 1-like 1 |
| Gene | CDKAL1 |
| UniProt ID | Q9Y5J9 |
| Molecular Weight | ~62 kDa |
| Subcellular Localization | Cytoplasm |
| Protein Family | CDKAL1 family |
| Function | tRNA modification, translational control |
CDKAL1 (CDK5 Regulatory Subunit Associated Protein 1-like 1) is a highly conserved protein encoded by the CDKAL1 gene. Originally identified as a CDK5 regulatory subunit-associated protein, CDKAL1 has been extensively studied for its role in type 2 diabetes mellitus (T2DM) risk. More recent research has revealed functions in the nervous system, with implications for Parkinson's disease, Alzheimer's disease, and other neurological conditions [1].
CDKAL1 is a 583-amino acid protein with several functional domains:
CDKAL1 is a member of the methyltransferase family:
CDKAL1 interacts with the CDK5/p35 complex:
GWAS have identified CDKAL1 variants associated with Parkinson's disease risk:
How CDKAL1 dysfunction may contribute to PD:
The dual association with T2DM and PD suggests shared pathways:
In Alzheimer's disease, CDKAL1 may play roles through:
CDKAL1 variants have been associated with:
Evidence suggests links to:
Understanding CDKAL1's role reveals potential therapeutic strategies:
CDKAL1 genetic variants may serve as:
CDKAL1 is a methyltransferase protein involved in tRNA modification and translational control. Originally studied in the context of type 2 diabetes, CDKAL1 has emerged as a risk factor for Parkinson's disease and other neurological disorders. The dual association with metabolic disease and neurodegeneration highlights the importance of cellular metabolism in neuronal health. Further research into CDKAL1 function may reveal novel therapeutic approaches for PD and AD.